A Study to Evaluate Safety and Efficacy of ASP015K in Patients With Rheumatoid Arthritis (RA) Who Had an Inadequate Response to DMARDs

NCT02308163 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

509

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Peficitinib
DRUG: Placebo
BIOLOGICAL: Etanercept

Sponsor

Astellas Pharma Inc